See this page online at: http://www.biotechfocus.com/2009Issue3
Sign up for your free subscription and keep up-to-date.
Stay updated on the latest news and technologies with Bioscienceworld's newsletters.
Five to choose from.
|
Biotechnology On The Food Safety Front
By Matt Barron
With more than 11 million cases of food-borne illness in Canada every year, it may come as a surprise to some that several bacterial culprits of these ailments, such as salmonella, were not recognized as causes of food-borne illness until 25 years ago. |
|
Q&A With Enterprise Saskatchewan
By Tonya Costoff
We asked and you responded. Readers gave us their thoughts on what they think the Canadian government needs to be doing when it comes to biotech. |
|
American VC Is No Fan Of Section 116
By Shawn Lawrence
In the February issue of Biotechnology Focus we introduced our readers to Section 116. We looked at the issues and concerns surrounding it from the point of view of lawyers from both the U.S. and Canada. This month we revisit the same issue, but this time from the point of view of a U.S. venture capitalist. |
|
BioDiscovery Toronto: Driving Early Stage Pre-Commercial Projects
By Shawn Lawrence
University and hospital research make up 30% of Canada's R&D effort, which compliments industry's 50% contribution. |
|
China's Century Bet On Biotechnology And A Pharmaceutical Industry - Shanghai Zhangjiang Hi-Tech Park
By Bill L. Qin (Lei Qin)
Within the last two decades, "Made in China" has been seen everywhere but mainly on consumable cheap products and it has been mocked as "trading airplanes with billions of T-shirts". |
|
Breaking The Paradox: What's Keeping Canada's Biotechnology Companies From Meeting Their HR Needs?
By Colette Rivet, executive director, BioTalent Canada
For companies in Canada's bio-economy, the relationship between capital and human resources is something of a Catch-22: attracting and retaining talent requires money, yet investment is drawn in large part by the talent on a company's team. |
|
Biotechnology And Countries Around The World
By Desiree Garland
Canada enjoys many natural advantages over other countries but it must clearly define its strategy and place in the biotechnology industry to live up to its potential. These governments understand the benefits of biotechnology and have either established themselves as major players in the industry or are emerging as world-class biotechnology centres. |